Plastic Surgery

Consensus core outcome set for facial aging trials established

A Delphi process with patients and clinicians produced a six-domain core outcome set for facial aging trials. Domains include treatment convenience, time to return to normal activity, focused area assessment at peak benefit, duration of effect, severity of persistent adverse events, and patient satisfaction. Authors recommend these six domains be reported in future randomized or controlled trials to improve comparability and meta-analysis. 1

Equity, diversity, and inclusion seldom embedded in pivotal device trials

Scoping review of 74 pivotal device investigations found basic demographics reported but limited analytic integration of EDI principles. Only 18.9% performed age subgroup analyses and 14.8% performed sex subgroup analyses; race/ethnicity appeared in 35.1% of reports. Explicit EDI framing in design occurred in 2.7%, and no study used CONSORT-Equity, limiting assessment of external validity. 2

Nationwide variability in insurance coverage for gender-affirming surgery

Policy review of 144 insurer-state policies covering 77% of the U.S. market found overall GAS coverage of 67.7%. Coverage varied widely by procedure: fertility cryopreservation 6.6%, facial feminization 37.3%, and GAS reversal 65.7%. WPATH concordance was 61.9%, and coverage, plus information access, was worse in Southern states. 3